Our findings support a role for R-EBUS-guided bronchial brushing samples in the cytological diagnosis and EGFR mutation analysis in patients with peripheral non-squamous NSCLC, thus allowing patients to avoid more invasive procedures. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.